{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:44:44Z","timestamp":1789595084773,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"crossref","award":["GAP-2176"],"award-info":[{"award-number":["GAP-2176"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","award":["GAP-2192"],"award-info":[{"award-number":["GAP-2192"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00203-025-04238-x","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T10:58:09Z","timestamp":1736938689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting InhA in drug-resistant Mycobacterium tuberculosis: potent antimycobacterial activity of diaryl ether dehydrozingerone derivatives"],"prefix":"10.1007","volume":"207","author":[{"given":"Mohamad Mosa","family":"Mubarak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadiya Amin","family":"Kantroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdoous Ahmad","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahoor","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"4238_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106125","volume":"129","author":"OA Abdelaziz","year":"2022","unstructured":"Abdelaziz OA, Othman DIA, Abdel-Aziz MM, Badr SMI, Eisa HM (2022) Novel diaryl ether derivatives as InhA inhibitors: design, synthesis and antimycobacterial activity. Bioorg Chem 129:106125. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106125","journal-title":"Bioorg Chem"},{"key":"4238_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100081","volume":"2","author":"SK Ahmed","year":"2024","unstructured":"Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA et al (2024) Antimicrobial resistance: impacts, challenges, and future prospects. J Med Surg Public Health 2:100081. https:\/\/doi.org\/10.1016\/j.glmedi.2024.100081","journal-title":"J Med Surg Public Health"},{"key":"4238_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2021.100285","volume":"25","author":"TA Black","year":"2021","unstructured":"Black TA, Buchwald UK (2021) The pipeline of new molecules and regimens against drug-resistant tuberculosis. J Clin Tuberc Other Mycobact Dis 25:100285. https:\/\/doi.org\/10.1016\/j.jctube.2021.100285","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"4238_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.5588\/ijtld.15.0864","volume":"20","author":"VR Bollela","year":"2016","unstructured":"Bollela VR, Namburete EI, Feliciano CS, Macheque D, Harrison LH, Caminero JA (2016) Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis. Int J Tuberc Lung Dis 20:1099\u20131104. https:\/\/doi.org\/10.5588\/ijtld.15.0864","journal-title":"Int J Tuberc Lung Dis"},{"key":"4238_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115646","volume":"259","author":"M Chebaiki","year":"2023","unstructured":"Chebaiki M, Delfourne E, Tamhaev R, Danoun S, Rodriguez F, Hoffmann P et al (2023) Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA. Eur J Med Chem 259:115646. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115646","journal-title":"Eur J Med Chem"},{"key":"4238_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejmech.2018.01.047","volume":"146","author":"A Chollet","year":"2018","unstructured":"Chollet A, Maveyraud L, Lherbet C, Bernardes-G\u00e9nisson V (2018) An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors. Eur J Med Chem 146:318\u2013343. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.047","journal-title":"Eur J Med Chem"},{"issue":"7","key":"4238_CR44","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1021\/acsinfecdis.3c00238","volume":"9","author":"R Chowdhary","year":"2023","unstructured":"Chowdhary R, Mubarak MM, Kantroo HA, Ur Rahim J, Malik A, Sarkar AR, Bashir G, Ahmad Z, Rai R (2023) Synthesis, characterization, and antimicrobial activity of ultra-short cationic \u03b2-Peptides. ACS Infect Dis 9(7):1437\u20131448.https:\/\/doi.org\/10.1021\/acsinfecdis.3c00238","journal-title":"ACS Infect Dis"},{"issue":"7","key":"4238_CR42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1021\/acsinfecdis.3c00238","volume":"9","author":"R Chowdhary","year":"2023","unstructured":"Chowdhary R, Mubarak MM, Kantroo HA, Ur Rahim J, Malik A, Sarkar AR, Bashir G, Ahmad Z, Rai R (2023) Synthesis, characterization, and antimicrobial activity of ultra-short cationic \u03b2-Peptides. ACS Infect Dis 9(7):1437\u20131448.https:\/\/doi.org\/10.1021\/acsinfecdis.3c00238","journal-title":"ACS Infect Dis"},{"key":"4238_CR7","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","volume":"12","author":"P Dadgostar","year":"2019","unstructured":"Dadgostar P (2019) Antimicrobial resistance: implications and costs. Infect Drug Resist 12:3903\u20133910. https:\/\/doi.org\/10.2147\/IDR.S234610","journal-title":"Infect Drug Resist"},{"key":"4238_CR8","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"4238_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","volume":"20","author":"VA Dartois","year":"2022","unstructured":"Dartois VA, Rubin EJ (2022) Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol 20:685\u2013701. https:\/\/doi.org\/10.1038\/s41579-022-00731-y","journal-title":"Nat Rev Microbiol"},{"key":"4238_CR10","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/jac\/dkq374","volume":"65","author":"JEM de Steenwinkel","year":"2010","unstructured":"de Steenwinkel JEM, de Knegt GJ, ten Kate MT, van Belkum A, Verbrugh HA, Kremer K et al (2010) Time\u2013kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis. J Antimicrob Chemother 65:2582\u20132589. https:\/\/doi.org\/10.1093\/jac\/dkq374","journal-title":"J Antimicrob Chemother"},{"issue":"17","key":"4238_CR11","doi-asserted-by":"publisher","first-page":"30079","DOI":"10.1016\/S2213-2600(17)30079-6","volume":"S2213\u20132600","author":"K Dheda","year":"2017","unstructured":"Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M et al (2017) The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med S2213\u20132600(17):30079\u201330086. https:\/\/doi.org\/10.1016\/S2213-2600(17)30079-6","journal-title":"Lancet Respir Med"},{"key":"4238_CR12","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jac\/dkl393","volume":"58","author":"GL French","year":"2006","unstructured":"French GL (2006) Bactericidal agents in the treatment of MRSA infections\u2014the potential role of daptomycin. J Antimicrob Chemother 58:1107\u20131117. https:\/\/doi.org\/10.1093\/jac\/dkl393","journal-title":"J Antimicrob Chemother"},{"key":"4238_CR13","doi-asserted-by":"publisher","first-page":"13206","DOI":"10.1038\/s41598-020-69995-9","volume":"10","author":"I Greco","year":"2020","unstructured":"Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL et al (2020) Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Sci Rep 10:13206. https:\/\/doi.org\/10.1038\/s41598-020-69995-9","journal-title":"Sci Rep"},{"key":"4238_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/c8md00472b","volume":"10","author":"L Guan","year":"2018","unstructured":"Guan L, Yang H, Cai Y, Sun L, Di P, Li W et al (2018) ADMET-score\u2014a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm 10:148\u2013157. https:\/\/doi.org\/10.1039\/c8md00472b","journal-title":"Medchemcomm"},{"key":"4238_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bmc.2015.12.049","volume":"24","author":"GA Hampannavar","year":"2016","unstructured":"Hampannavar GA, Karpoormath R, Palkar MB, Shaikh MS (2016) An appraisal on recent medicinal perspective of curcumin degradant: dehydrozingerone (DZG). Bioorg Med Chem 24:501\u2013520. https:\/\/doi.org\/10.1016\/j.bmc.2015.12.049","journal-title":"Bioorg Med Chem"},{"key":"4238_CR16","doi-asserted-by":"publisher","first-page":"750496","DOI":"10.3389\/fimmu.2021.750496","volume":"12","author":"K Horv\u00e1ti","year":"2021","unstructured":"Horv\u00e1ti K, Fodor K, P\u00e1lyi B, Henczk\u00f3 J, Balka G, Gyulai G et al (2021) Novel assay platform to evaluate intracellular killing of mycobacterium tuberculosis: in vitro and in vivo validation. Front Immunol 12:750496. https:\/\/doi.org\/10.3389\/fimmu.2021.750496","journal-title":"Front Immunol"},{"key":"4238_CR17","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.3390\/molecules25143125","volume":"25","author":"TS Ibrahim","year":"2020","unstructured":"Ibrahim TS, Taher ES, Samir E, Malebari AM, Khayyat AN, Mohamed MFA et al (2020) In vitro antimycobacterial activity and physicochemical characterization of diaryl ether triclosan analogues as potential InhA reductase inhibitors. Molecules 25:3125. https:\/\/doi.org\/10.3390\/molecules25143125","journal-title":"Molecules"},{"key":"4238_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3109\/14756361003671045","volume":"25","author":"SG Kini","year":"2010","unstructured":"Kini SG, Bhat A, Pan Z, Dayan FE (2010) Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives. J Enzyme Inhib Med Chem 25:730\u2013736. https:\/\/doi.org\/10.3109\/14756361003671045","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4238_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2018.05.013","volume":"42","author":"A Koch","year":"2018","unstructured":"Koch A, Cox H, Mizrahi V (2018) Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment. Curr Opin Pharmacol 42:7\u201315. https:\/\/doi.org\/10.1016\/j.coph.2018.05.013","journal-title":"Curr Opin Pharmacol"},{"key":"4238_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s13365-018-0703-8","volume":"25","author":"A Krumina","year":"2019","unstructured":"Krumina A, Chapenko S, Kenina V, Mihailova M, Logina I, Rasa S et al (2019) The role of HHV-6 and HHV-7 infections in the development of fibromyalgia. J Neurovirol 25:194\u2013207. https:\/\/doi.org\/10.1007\/s13365-018-0703-8","journal-title":"J Neurovirol"},{"issue":"7","key":"4238_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/07391102.2020.1808072","volume":"9","author":"N Kumar","year":"2022","unstructured":"Kumar N, Awasthi A, Kumari A, Sood D, Jain P, Singh T, Sharma N, Grover A, Chandra R (2022) Antitussive noscapine and antiviral\ndrug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis. J Biomol Struct Dyn 40(1):101\u2013116. https:\/\/doi.org\/10.1080\/07391102.2020.1808072","journal-title":"J Biomol Struct Dyn"},{"key":"4238_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.100934","volume":"5","author":"C Kumar","year":"2023","unstructured":"Kumar C, Mubarak MM, Singh CP, Chauhan N, Satti NK, Yadav G et al (2023) Synthetic modification of dehydrozingerone and their biological evaluation for anti-tubercular and anti-inflammatory potency. Results Chem 5:100934. https:\/\/doi.org\/10.1016\/j.rechem.2023.100934","journal-title":"Results Chem"},{"key":"4238_CR22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00044-023-03039-5","volume":"32","author":"MS Lone","year":"2023","unstructured":"Lone MS, Mubarak MM, Nabi SA, Wani FR, Amin S, Nabi S et al (2023) Isonicotinoyl-butanoic acid hydrazone derivatives as anti-tubercular agents: in-silico studies, synthesis, spectral characterization and biological evaluation. Med Chem Res 32:808\u2013826. https:\/\/doi.org\/10.1007\/s00044-023-03039-5","journal-title":"Med Chem Res"},{"key":"4238_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1380848","author":"J Mi","year":"2024","unstructured":"Mi J, Wu X, Liang J (2024) The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1380848","journal-title":"Front Microbiol"},{"key":"4238_CR26","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1128\/AAC.00474-11","volume":"55","author":"S Ram\u00f3n-Garc\u00eda","year":"2011","unstructured":"Ram\u00f3n-Garc\u00eda S, Ng C, Anderson H, Chao JD, Zheng X, Pfeifer T et al (2011) Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. Antimicrob Agents Chemother 55:3861\u20133869. https:\/\/doi.org\/10.1128\/AAC.00474-11","journal-title":"Antimicrob Agents Chemother"},{"key":"4238_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jgar.2021.03.015","volume":"25","author":"MA Rather","year":"2021","unstructured":"Rather MA, Bhat ZS, Lone AM, Maqbool M, Bhat BA, Ahmad Z (2021) In vitro potency of 2-(((2-hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione against drug-resistant and non-replicating persisters of Mycobacterium tuberculosis. J Glob Antimicrob Resist 25:202\u2013208. https:\/\/doi.org\/10.1016\/j.jgar.2021.03.015","journal-title":"J Glob Antimicrob Resist"},{"key":"4238_CR28","volume-title":"Assay guidance manual","author":"TL Riss","year":"2004","unstructured":"Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ et al (2004) Cell viability assays. In: Markossian S, Grossman A, Arkin M, Auld D, Austin C, Baell J et al (eds) Assay guidance manual. Bethesda, Eli Lilly & Company and the National Center for Advancing Translational Sciences"},{"key":"4238_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103498","volume":"95","author":"F Rodriguez","year":"2020","unstructured":"Rodriguez F, Saffon N, Sammartino JC, Degiacomi G, Pasca MR, Lherbet C (2020) First triclosan-based macrocyclic inhibitors of InhA enzyme. Bioorg Chem 95:103498. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103498","journal-title":"Bioorg Chem"},{"key":"4238_CR30","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3390\/ijms24032914","volume":"24","author":"IP S\u00e6b\u00f8","year":"2023","unstructured":"S\u00e6b\u00f8 IP, Bj\u00f8r\u00e5s M, Franzyk H, Helgesen E, Booth JA (2023) Optimization of the hemolysis assay for the assessment of cytotoxicity. Int J Mol Sci 24:2914. https:\/\/doi.org\/10.3390\/ijms24032914","journal-title":"Int J Mol Sci"},{"key":"4238_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017863","volume":"5","author":"KJ Seung","year":"2015","unstructured":"Seung KJ, Keshavjee S, Rich ML (2015) Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med 5:a017863. https:\/\/doi.org\/10.1101\/cshperspect.a017863","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4238_CR32","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00044-010-9405-3","volume":"20","author":"M Singh","year":"2011","unstructured":"Singh M, Sasi P, Rai G, Gupta VH, Amarapurkar D, Wangikar PP (2011) Studies on toxicity of antitubercular drugs namely isoniazid, rifampicin, and pyrazinamide in an in vitro model of HepG2 cell line. Med Chem Res 20:1611\u20131615. https:\/\/doi.org\/10.1007\/s00044-010-9405-3","journal-title":"Med Chem Res"},{"key":"4238_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1021\/jm030182i","volume":"47","author":"S Sivaraman","year":"2004","unstructured":"Sivaraman S, Sullivan TJ, Johnson F, Novichenok P, Cui G, Simmerling C et al (2004) Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues. J Med Chem 47:509\u2013518. https:\/\/doi.org\/10.1021\/jm030182i","journal-title":"J Med Chem"},{"key":"4238_CR34","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1039\/D3MD00518F","volume":"15","author":"B Teli","year":"2024","unstructured":"Teli B, Mubarak MM, Ahmad Z, Bhat BA (2024) Trifluoroacetic acid-mediated synthesis of xanthene constructs and their extensive anti-tuberculosis evaluation. RSC Med Chem 15:1295\u20131306. https:\/\/doi.org\/10.1039\/D3MD00518F","journal-title":"RSC Med Chem"},{"key":"4238_CR35","unstructured":"Tuberculosis (n.d.) https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis (accessed September 2, 2024)."},{"key":"4238_CR36","unstructured":"Tuberculosis: multidrug-resistant (MDR-TB) or rifampicin-resistant TB (RR-TB) (n.d.). https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/tuberculosis-multidrug-resistant-tuberculosis-(mdr-tb). Accessed 2 Sept 2024"},{"key":"4238_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa AN, Subbian S, Hanna LE, Selvakumar N (2016) Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evol 45:474\u2013492. https:\/\/doi.org\/10.1016\/j.meegid.2016.09.004","journal-title":"Infect Genet Evol"},{"key":"4238_CR38","unstructured":"WHO (2020.) Global TB progress at risk. https:\/\/www.who.int\/news\/item\/14-10-2020-who-global-tb-progress-at-risk. Accessed 2 Sept 2024"},{"key":"4238_CR39","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.bmcl.2011.12.022","volume":"22","author":"Y Yang","year":"2012","unstructured":"Yang Y, Wang Z, Yang J, Yang T, Pi W, Ang W et al (2012) Design, synthesis and evaluation of novel molecules with a diphenyl ether nucleus as potential antitubercular agents. Bioorg Med Chem Lett 22:954\u2013957. https:\/\/doi.org\/10.1016\/j.bmcl.2011.12.022","journal-title":"Bioorg Med Chem Lett"},{"key":"4238_CR40","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","volume":"35","author":"H Yang","year":"2019","unstructured":"Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z et al (2019) admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35:1067\u20131069. https:\/\/doi.org\/10.1093\/bioinformatics\/bty707","journal-title":"Bioinformatics"},{"key":"4238_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.743923","author":"SA Yoon","year":"2021","unstructured":"Yoon SA, Park SY, Cha Y, Gopala L, Lee MH (2021) Strategies of detecting bacteria using fluorescence-based dyes. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2021.743923","journal-title":"Front Chem"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04238-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04238-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04238-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:16:50Z","timestamp":1738757810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04238-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["4238"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04238-x","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"34"}}